CENTRAL COUNCIL FOR RESEARCH IN HOMEOPATHY

Research Institutes/Units state-wise with research projects and other activities during the last three years and the current year -Andaman and Nicobar- Andhra Pradesh

noreply@blogger.com (devendra Kumar munta) — Fri, 10 May 2013 06:31:00 +0000

1.	Andaman and Nicobar	Clinical Research Unit (H), M.B. 31, Middle Point, Mahatma Gandhi Road, Port Blair (A&N)- 744101.	1. 2.	Clinical Research a) Furunculosis b) Acute Rhinitis in Children Clinical Verification	1. 2.	Clinical Research a) Influenza b) Leptospirosis Clinical Verifi cation	1. Clinical Research a) Influenza b) Leptospirosis (Pilot study concluded in Nov. 2010) 2. Clinical Verification 3. Mother and Child Clinic 4. Community awareness camps on Mother and Child care	1. 2. 3. 4.	Clinical Research Leptospirosis (RCT) Clinical Verification Research Program Mother and Child Clinic Community awareness camps on Mother and Child care	1. Clinical Research Benign Prostatic Hyperplasia (RCT) 2. Clinical Verification Research Program 3. Rheumatology clinic 4. Mother and Child Clinic 5. Outreach programme for Medicare service in the adopted village	1. Clinical Research a) Benign Prostatic Hyperplasia (RCT) b) Gastro Esophageal Reflux Disease* c) Gout * 2. Clinical Verification Research Program 3. Rheumatology clinic 4. Mother and Child Clinic 5. Outreach programme for Medicare service in the adopted village
1.	Andaman and Nicobar	Extension Centre of Clinical Research Unit (Homoeopathy) at CHC , Diglipur	-		-		-	-		Leptospirosis (RCT)	Leptospirosis (RCT)

Statement of Amount released by the Department during last 5 years

noreply@blogger.com (devendra Kumar munta) — Fri, 10 May 2013 06:03:00 +0000

Central Council for Research in Homoeopathy

Statement of Amount released by the Department during last 5 years

(Rupees in lakhs)

PERIOD		PLAN	NON -PLAN	TOTAL
	2009-2010	2,987.00	1,365.00	4,352.00
	2010-2011	3,392.00	1,480.00	4,872.00
	2011-2012	3,220.00	1,670.00	4,890.00
	2012-2013	4,986.00	1,908.10	6,894.10
	2013-2014	6,200.00	1,769.00	7,969.00
		20,785.00	8,192.10	28,977.10

ccrh@del3.vsnl.net.in

Source: http://ccrhindia.org/accounts.asp

HOMEOPATHY SCIENCE OF GENTLE HEALING - FROM CCRH

noreply@blogger.com (devendra Kumar munta) — Fri, 26 Apr 2013 07:28:00 +0000

HOMEOPATHY SCIENCE OF GENTLE HEALING

CONTENTS

Foreward iii

Preface v

Acknowledgment vii

Contents ix

List of Figures xi

List of Tables xv

Abbreviations xvii

Executive Summary xix

Introduction 1-17

1.1Evolution of Homoeopathy 2

1.2Current Global Scenario 4

1.3Homoeopathy in India 5

1.3.1Major Milestones 5

1.3.2Infrastructure and Network 11

1.3.3International Co-operation 13

1.4Organisation of Document 16

2Principle and Scope 18-24

2.1Principles of Homoeopathy 18

2.2Therapeutic Approaches 20

2.3Scope and Advantages 22

3Research and Development 25-85

3.1Central Council for Research in Homoeopathy 27

3.2Extra Mural Research 37

3.3AYUSH Research Portal 38

3.4Research Outcomes 39

3.4.1Clinical Research 39

3.4.2Basic Research 63

3.4.3Literary Research 84

3.5Road Ahead 85

4Drug Development and Regulation 86-106

4.1Homoeopathic Pharmacopoeia Laboratory 86

4.2Drug Standardization 90

4.3Drug Proving 92

4.4Clinical Verification 93

4.5Drug Regulation and Quality Control 94

4.6Drug Manufacturing Industry 95

4.7Important Medicinal Plants Used in Homoeopathy 97

5Education and Practice 107-124

5.1Education 107

5.2Educational Institutions 108

5.3National Institute of Homoeopathy 110

5.4Central Council of Homoeopathy 112

5.5Clinical Practice 113

5.6Homoeopathic Associations 115

6Further Reading 117-120

6.1List of Publications by CCRH 117

6.2Important Websites 120

Glossary 121

Credits

Source: http://ccrhindia.com

INDIAN JOURNAL OF RESEARCH IN HOMOEOPATHY Volume 5, No. 1, 2011

noreply@blogger.com (devendra Kumar munta) — Fri, 12 Apr 2013 13:41:00 +0000

Contents

Title Page

• Editorial

C. Nayak i

• Fundamental Research

Homeopathic drugs Natrum sulphuricum and Carcinosin prevent azo 1

dye-induced hepatocarcinogenesis in mice

Nandini Bhattacharjee, Pathikrit Banerjee and Anisur Rahman Khuda-Bukhsh

• Drug Proving

Mimosa humilis: A multicentric double blind Homoeopathic Pathogenetic Trial 16

C. Nayak, Vikram Singh, V.A. Siddiqui, Rajpal, S. Prakash, Yogender Rai, N.R. Dey

• Drug Standardization

Quality Assurance of Raw Drug Euphorbia hypericifolia through microscopic studies. 21

H.C. Gupta and P Padma Rao

• Clinical Verification

Tarentula hispanica - A Multicentric Clinical Verification Study conducted by CCRH 25

P.S.Chakraborty, Anil Khurana, J.P.Singh, M.K.Rai, Pramodji Singh,

A.K.Vichitra, A.K.N.Singh, Deepa Chakraborty, D.K.Singh, Hari Singh,

Mohan Singh, M.N.Sinha, Rajpal,^, R.K.Rai, S.Prakash, S.D.Pathak,

S.R.Bhagat, Vikram Singh, Vijay K. Paul, V.K.Singh, Yogendar Rai & V.A. Siddiqui

• Clinical Research

Treating Benign Prostatic Hyperplasia in elderly Men with 37

Homoeopathy – a series of eleven cases

G. Ravi Chandra Reddy, Praveen Oberai, Vikram Singh, C. Nayak

• Collaborative Research

Biochemical and haematological evaluation of homoeopathic	44
drug Tribulus terrestris in rats

E. N. Sundaram, K. P. Singh, P. Uma Maheswara Reddy, K. R.J.Nair, C.Nayak

• Extra Mural Research

A Randomized Double Blind Clinical Trial of A Homoeopathic Medicine 54

In The Treatment Of Trophic Ulcer And Neuropathy In Leprosy

D Chakraborty, T Chakraborty, S. Das & J Sengupta

• Case Record

A Case of Depressive disorder & Tension Headache 66

Reeta Bagai, Manas R Sarangi

• Instructions to Authors 69

World Homeopathic Day 2013 & a new publication on Homeopathy

noreply@blogger.com (devendra Kumar munta) — Fri, 12 Apr 2013 12:36:00 +0000

Homoeopathy - Science of Gentle Healing

On the occasion of World Homoeopathic Day, it is my privilege to inform you that the Department of AYUSH, Ministry of Health and Family Welfare, Government of India has published ‘Homoeopathy - Science of Gentle Healing’, which traces the development of Homoeopathy and its successful institutionalization in India.

The chapter on research and development provides a ready reference of the studies of some published clinical and basic research studies conducted by Indian scientists. The efforts and achievements of the Government in development and standardization of the drugs, particularly related to incorporating drugs of Indian origin in the Homoeopathic Materia Medica has been outlined. The infrastructure and mechanisms ensuring quality education and practice of Homoeopathy have also been detailed.

The publication has been developed through a consultative process involving numerous experts and peers in the field and would be a useful resource for policy makers, researchers, academicians, practitioners and students. The E-book in (html format) is available on the website of the Council and can be accessed through the link www.ccrhindia.org\dossier\index.html free of cost. We welcome your valuable feedback. You are welcome to forward this mail to all your contacts.

Yours sincerely

Dr.Anil Khurana

Asstt. Director(H)

Central Council for Research in Homoeopathy

under Department of AYUSH, Ministry of Health & Family Welfare

Government of India
911127619

INDIAN JOURNAL OF RESEARCH IN HOMOEOPATHY Volume 4, No. 4, 2010

noreply@blogger.com (devendra Kumar munta) — Wed, 10 Apr 2013 04:21:00 +0000

Contents

Title Page

· EDITORIAL

C. Nayak

· DRUG PROVING

Ocimum sanctum- A multicentric double blind homoeopathic pathogenetic trial 1

Rajpal, Vinay Kr. Singh, R.K. Roy, C.P. Chaudhary, P.C. Mal, A.K. Bhakat

Drug Standardisation

Standardization studies on Cuscuta reflexa Roxb. – A new homoeopathic drug 7

C. Nayak, P. Subramanian, H.C. Gupta, P. Padma Rao, D.S. Kushwaha

· Clinical Verification

Tylophora indica- A multicentric clinical verification study 12

C. Nayak, Vikram Singh, Krishna Singh, P.S. Chakraborty, Subhash Kaushik,

R.K. Ray, R.P. Yadav, M.K. Rai, Darshan Singh, A.K. Bhakat, V.K. Singh, M.D. John, K.C. Das, V.G. Prasad, S.S. Nain, Mohan Singh, P.K. Chandra, D.K. Singh, Y. Rai, Pramodji Singh, Ojit Singh, A.K. N. Singh, M. Shah, P.K. Pradhan, R.Bavaskar, Debata, C.D. Lamba, S. A. Ali

· Clinical Research

Homoeopathic medicinal treatment of autism 19

Neeraj Gupta, R. K. Saxena, A .K Malhotra, Ritu Juneja

Effectiveness of homoeopathic medicines in HIV patients - A clinical trial 29

K.C. Muraleedharan, S.K. Dey, Popula Prasad, V.A. Siddiqui, Rupali Dixit,

Vikram Singh, C. Nayak

Extra Mural Research

An approach to acute diarrhoeal disorders through sector and constitutional

homoeopathic treatment in tribal children attending balwadis 36

Patel Manoj, Navin Pawaskar, Pradeep Mundra, Prashant Tamboli, Gandhali Kothare

Collaborative Reseach

Evidence based clinical study to assess the usefulness of homoeopathic

medicines in patients of Benign Prostatic Hyperplasia 49

Girish Gupta, J.P. Singh, Salil Tandon, Santosh Singh, C. Nayak, Hari Singh,

Ch. Raveendar, K.R.J. Nair, Praveen Oberai

Instructions to Authors

Source: http://ccrhindia.org/4(4).asp

INDIAN JOURNAL OF RESEARCH IN HOMOEOPATHY -Volume 4, No. 3, 2010

noreply@blogger.com (devendra Kumar munta) — Tue, 09 Apr 2013 15:36:00 +0000

Contents

Title Page

EDITORIAL 00

C. Nayak

· FUNDAMENTAL RESEARCH

In search of a technique for identifying potentised homoeopathic medicines beyond

Avogadro limit 1

T. Maity, D. Ghosh, C.R. Mahata

· DRUG PROVING

Azadirachta indica - A multicentric double blind homoeopathic pathogenetic trial 10

Rajpal, Anil Khurana, Vinay Kumar Singh, Reeta Bagai, C.P. Chaudhari, R.D. Jayant

· DRUG STANDARDISATION

Pharmacognostic study of Echinacea purpurea (L.) Moench. 17

P. Subramanian, P. Padma Rao, H. Baig, H.C. Gupta, P.R. Reddy, C. Nayak

· CLINICAL VERIFICATION

Glycyrrhiza glabra - A multicentric clinical verification study 22

C. Nayak, Vikram Singh, Krishna Singh, P.S. Chakraborty, Subhash Kaushik, R.K. Ray, R.P. Yadav, M.K. Rai^,, Darshan Singh, A.K. Bhakat, V.K. Singh, M.D. John, K.C. Das, V.G. Prasad, S.S. Nain, Mohan Singh, P.K. Chandra, D.K. Singh, Y. Rai, Pramodji Singh, Ojit Singh, A.K.N. Singh, M. Shah,P.K. Pradhan, R. Bavaskar, L. Debata, C. D. Lamba, S. A. Ali

· CLINICAL RESEARCH

To explore the utility of Homoeopathic medicine Lycopodium clavatum in

Urinary calculi 34

C. Nayak, Vikram Singh, V.A. Siddiqui, Rupali Dixit

· COLLABORATIVE RESEACH

Preliminary studies on analgesic and behavioural activities of the homoeopathic

formulations of Chenopodium ambrosioides in experimental animal models 44

E.N. Sundaram, K.P. Singh, K. Pratap Reddy, P. Umamaheshwara Reddy, Ch. Raveendar,

K.R.J. Nair, C. Nayak

· CASE RCASE RECORD

Homoeopathic management of uterine leiomyomata: A case report 51

Anita Sharma

INSTRUCTIONS TO AUTHORS

Senior Research Fellow Homeopathy vacancies at CCRH across India

noreply@blogger.com (devendra Kumar munta) — Mon, 08 Apr 2013 05:19:00 +0000

Add caption

Walk-in-interview for Senior Research Fellow Homeopathy vacancies at CCRH across India

Advertisement No.03/2013
The Central Council for Research in Homoeopathy (CCRH), New Delhi, an autonomous body under the Department of AYUSH, Ministry of Health and Family Welfare, Government of India intends to engage the following categories of personnel on contract basis for posting in its peripheral Institutes/Units located throughout the country.

The engagement will be purely on contract basis and selection will be made through walk-in- Interview:-

Senior Research Fellow (Homoeopathy) – Interview date: 16th April, 2013 at 10.00 a.m.
Senior Research Fellow (Chemistry) – Interview date: 16th April, 2013 at 10.00 a.m.
Stenographers – Interview date: 11th April, 2013 at 10.00 a.m.
Hindi Translator – Interview date: 12th April, 2013 at 10.00 a.m.

The details, that is, number of posts, place of posting, essential qualification, experience, remuneration, place of walk-in-interview, date of interview etc. are available at Council’s website www.ccrhindia.org.

INDIAN JOURNAL OF RESEARCH IN HOMOEOPATHY Volume 4, No. 2, 2010

noreply@blogger.com (devendra Kumar munta) — Fri, 05 Apr 2013 06:01:00 +0000

Contents

Title Page

• EDITORIAL

C. Nayak i

• FUNDAMENTAL RESEARCH

Decreased intensity of Japanese Encephalitis virus infection in chick

chorioallantoic membrane under influence of ultradiluted Belladonna extract 1

Bhaswati Bandyopadhyay, Satadal Das, Milan Sengupta, Chandan Saha,

Kartick Chandra Das, Debabrata Sarkar, Chaturbhuj Nayak

• DRUG PROVING

Carica papaya - a multicentric double blind homoeopathic pathogenetic trial 7

Rajpal, Anil Khurana, V.A. Siddiqui, V.K. Singh, B.N. Dutta, Shakti Dey, R.D. Jayant

• DRUG STANDARDIZATION

Standardisation of homoeopathic drug: Pastinaca sativa Linn. 13

P. Subramanian, P. Padma Rao, H.C. Gupta, Vikram Singh, C. Nayak

•CLINICAL VERIFICATION

Iris tenax - a multicentric clinical verification study 18

P.S. Chakraborty, A. Khurana, A.K.N. Singh, A.K. Vichitra, Deepa Chakraborty, D.K. Singh, Hari Singh, J.P. Singh, M.K. Rai, Mohan Singh, M.N. Sinha, Pramodji Singh, Rajpal, R.K. Rai, S. Prakash, S.D. Pathak, S.R. Bhagat, Vikram Singh, Vijay K. Paul, V.K. Singh, V.A. Siddiqui, Yogendar Rai

•CLINICAL RESEARCH

A multicentric open clinical trial to evaluate the usefulness of 13 predefined

homoeopathic medicines in the management of acute rhinitis in children 23

Chaturbhuja Nayak, Vikram Singh, Krishna Singh, Hari Singh, Praveen Oberai, Varanasi Roja, Maya Padmanabhan, Sunil Prasad, Manu Dev Arya, Punnackal Gopalan Mohanan, Ojit Singh, Manakkupara Devasia John, Nameirakpam Bir Kumar Singh, Swami Raj Bhagat, Sunil Ramteke

•EXTRA MURAL RESEARCH

Role of homoeopathic treatment in scabies infection in adivasi children

attending ashram shalas (resident schools) 33

Chandrasekhar Goda, Prashant Tamboli, Sharmila Patil,

Swarda Valimbe Kalyani Mhatre

• COLLABORATIVE RESEACH

A preliminary study to evaluate analgesic and behavioural activities of

the homoeopathic drug, Anagallis arvensis in rats 41

E.N. Sundaram, K.P. Singh, K. Pratap Reddy, P. Umamaheshwara Reddy,

K.R.J. Nair, Ch. Raveendar, C. Nayak

•INSTRUCTIONS TO AUTHORS 49

INDIAN JOURNAL OF RESEARCH IN HOMOEOPATHY - Volume 4, No. 1, 2010

noreply@blogger.com (devendra Kumar munta) — Wed, 03 Apr 2013 13:39:00 +0000

Contents

Title Page

•Editorial

C. Nayak i

Fundamental Research

Effect of homeopathic medicines on Transplanted Tumors in mice 1

ES Sunila, Girija Kuttan, Preethi KC, Ramadasan Kuttan

•Drug Proving

Skookum chuck - A multicentric double blind Homoeopathic Pathogenetic Trial 8

Anil Khurana, V.A. Siddiqui, Yogender Rai, S. Prakash and N.R. Dey

•Drug Standardization

Homoeopathic raw drug plant sources - II: Non Angiosperm Groups : Bryophytes, 15

Pteridophytes & Gymnosperms D. Suresh Baburaj and H.C. Gupta

Clinical Research

Usefulness of homoeopathic therapy in Distress During Climacteric Years 21

S.K. Bindra, Jaya Gupta, Vikram Singh and C. Nayak

A Prospective Multicenter Observational Study to evolve the usefulness 31

of the nine predefined homeopathic medicines in Furunculosis

C. Nayak, V. Singh, K. Singh, H. Singh, P. S. Chakravorty, S. Kaushik, V. Roja,

K. Patidar, M. Padmanabhan, R. P. Gupta, U. P. Yadav, A. Soren, B. Singh,

R. Bavaskar, P. K. Kundu and S. Kumar

•Case Record

Diabetic Distal Symmetric Polyneuropathy: A case study 38

Ch. Raveendar

•Collaborative Research

Effect of homeopathic drugs used in insomnia on serum melatonin and cortisol 47

levels in healthy volunteers

Gitanjali B, Nayak C, Raveendran R and Rao Prakash M

•Instructions to Authors 56

Source: http://ccrhindia.org/4(1).asp

INDIAN JOURNAL OF RESEARCH IN HOMOEOPATHY Volume 3, No. 4, 2009

noreply@blogger.com (devendra Kumar munta) — Mon, 01 Apr 2013 15:25:00 +0000

	Contents
	Title	Page
•	Editorial
	C. Nayak	i
•	Fundamental Research
	Homeopathic drugs Natrum sulphuricum and Carcinosin prevent azo	1
	dye-induced hepatocarcinogenesis in mice
	Nandini Bhattacharjee, Pathikrit Banerjee and Anisur Rahman Khuda-Bukhsh
•	Drug Proving
	Mimosa humilis: A multicentric double blind Homoeopathic Pathogenetic Trial	16

C. Nayak, Vikram Singh, V.A. Siddiqui, Rajpal, S. Prakash, Yogender Rai, N.R. Dey

• Drug Standardization

	Quality Assurance of Raw Drug Euphorbia hypericifolia through microscopic studies.	21
	H.C. Gupta and P Padma Rao
•	Clinical Verification
	Tarentula hispanica - A Multicentric Clinical Verification Study conducted by CCRH	25
	P.S.Chakraborty, Anil Khurana, J.P.Singh, M.K.Rai, Pramodji Singh,
	A.K.Vichitra, A.K.N.Singh, Deepa Chakraborty, D.K.Singh, Hari Singh,
	Mohan Singh, M.N.Sinha, Rajpal,^, R.K.Rai, S.Prakash, S.D.Pathak,
	S.R.Bhagat, Vikram Singh, Vijay K. Paul, V.K.Singh, Yogendar Rai & V.A. Siddiqui
•	Clinical Research
	Treating Benign Prostatic Hyperplasia in elderly Men with	37
	Homoeopathy – a series of eleven cases

G. Ravi Chandra Reddy, Praveen Oberai, Vikram Singh, C. Nayak

• Collaborative Research

Biochemical and haematological evaluation of homoeopathic	44
drug Tribulus terrestris in rats

E. N. Sundaram, K. P. Singh, P. Uma Maheswara Reddy, K. R.J.Nair, C.Nayak

• Extra Mural Research

	A Randomized Double Blind Clinical Trial of A Homoeopathic Medicine	54
	In The Treatment Of Trophic Ulcer And Neuropathy In Leprosy
	D Chakraborty, T Chakraborty, S. Das & J Sengupta
•	Case Record
	A Case of Depressive disorder & Tension Headache	66
	Reeta Bagai, Manas R Sarangi

• Instructions to Authors 69

INDIAN JOURNAL OF RESEARCH IN HOMOEOPATHY Volume 3, No. 3, 2009

noreply@blogger.com (devendra Kumar munta) — Fri, 29 Mar 2013 07:29:00 +0000

Contents

Title Page No.

•Editorial i

C. Nayak

• Fundamental Research

Inhibition of Chemically Induced Carcinogenesis by Drugs Used 1 in Homeopathic Medicine Hari Kumar, E.S. Sunila, Girija Kuttan, K.C. Preethi, Nimita Venugopal, Ramadasan Kuttan

• Drug Proving

Cuscuta reflexa: A Double Blind Homoeopathic Pathogenetic Trial 7 R. Shaw, V.A. Siddiqui, Rajpal, Vinay Kr. Singh, N.R. Dey

• Clinical Verification

Ephedra vulgaris: A Multicentric Clinical Verification Study conducted by CCRH 14 P.S. Chakraborty, A.K. Khurana, J.P. Singh, M.K. Rai, Pramodji Singh, A.K. Vichitra, A.K.N. Singh, Deepa Chakraborty, D.K. Singh, Hari Singh, Mohan Singh, M.N. Sinha, Rajpal, R.K. Rai, S. Prakash, S.D. Pathak, S.R. Bhagat, Vikram Singh, Vijay K. Paul, V.K. Singh, Yogendar Rai & V.A. Siddiqui

• Clinical Research

A Prospective Multicentric Observational Study to Evolve the Usefulness of 21 the Predefined Homoeopathic Medicines in the Management of Acute Diarrheal Disease in Children C. Nayak, Vikram Singh, K. Singh, Hari Singh, Anita Sharma, Praveen Oberai, Varanasi Roja, Debadatta Nayak, Maya Padmanabhan, Alok Mishra, G.C. Sehegal, Subhash Kaushik, C.P. Chowdhary, V.K. Singh, Sahid Ali, P. Hima Bindu, D.B. Sarkar

• Extra Mural Research

Prevalence of Thyroid Disorders in School Children In Delhi – Post Iodization Scenario 29 An epidemiological survey conducted under the first phase of EMR project on “Effects of Homoeopathic treatment on natural history of autoimmune thyroiditis” V.K. Chauhan, R.K. Manchanda, Archana Narang, R.K. Marwaha, Saurav Arora, Latika Nagpal

• Case Record

A Case of Vitiligo Treated by Sulphur 34 D.K. Jha, L. Debata

• Instructions to Authors 41

Source:http://ccrhindia.org/3(3).asp

INDIAN JOURNAL OF RESEARCH IN HOMOEOPATHY Volume 3, No. 2, 2009

noreply@blogger.com (devendra Kumar munta) — Thu, 28 Mar 2013 06:38:00 +0000

Contents

Title Page No.

• Editorial i

C. Nayak

• Fundamental Research

The Structure of Liquid Water; Novel Insights from Materials Research; 1 Potential Relevance to Homeopathy Rustum Roy, W.A. Tiller, Iris Bell, M.R. Hoover

• Drug Standardisation

Homoeopathic Raw Drug Plant Sources: Lower Groups-I: Algae, Macro & 25 Micro Fungi & Lichens Suresh Baburaj

• Drug Proving

Saraca indica: A multicentric double blind Homoeopathic Pathogenetic Trial 32

C. Nayak, V.A. Siddiqui, Rajpal, Vinay Kr. Singh, Hari Singh, Ramender Pal, Vikram Singh, R.K. Roy, S. Prakash, Yogender Rai, K.C. Das

• Clinical Verification

Alstonia Constricta: A Multicentric Clinical Verification Study conducted by CCRH 37

P.S. Chakraborty, J.P. Singh, M.K. Rai, Pramodji Singh, A.K. Vichitra, A.K.N. Singh, Deepa Chakraborty, D.K. Singh, Hari Singh, Mohan Singh, M.N. Sinha, Rajpal, R.K. Rai, S. Prakash, S.D. Pathak, S.R. Bhagat, Vikram Singh, Vijay K. Paul, V.K. Singh, Yogendar Rai & V.A. Siddiqui

• Clinical Research

A Follow-up Study on the Efficacy of the Homeopathic Remedy Arsenicum 43 Album in Volunteers Living in High Risk Arsenic Contaminated Areas Anisur Rahman Khuda-Bukhsh, Susanta Roy-Karmakar, Antara Banerjee, Pathikrit Banerjee, Surajit Pathak, Surjyo Jyoti Biswas, Saiful Haque, Debarsi Das, Naoual Boujedaini and Philippe Belon

• Case Record

An HIV Infected Individual Maintaining Asymptomatic Status for Ten Years 52 under Homoeopathic Treatment S. K. Dey

• Instructions to Authors 57

Source:http://ccrhindia.org/3(2).asp

INDIAN JOURNAL OF RESEARCH IN HOMOEOPATHY- Volume 3, No. 1, 2009

noreply@blogger.com (devendra Kumar munta) — Tue, 26 Mar 2013 07:31:00 +0000

Source: http://ccrhindia.org/3(1).asp

Contents

Title Page No.

• Editorial i

C. Nayak

• Fundamental Research

Chronic toxicological effects of high diluted solutions of Aveloz (Euphorbia tirucalli L.) 1 on healthy mice: a preliminary study Marcia CBN Varricchio (DSc), Cristiane Pereira, Fernanda Sales, Teresa Gomes, Elaine Daudt, Carolina Lessa Aquino, Gleyce Moreno Barbosa, Nelson Gomes, Alexandre dos Santos Pyrrho (DSc), Paulo Eduardo Mansur Hobaica, Morgana Castelo Branco (DSc), Ricardo Kuster, Carla Holandino (DSc)

• Drug Standardisation

Biochemical and haematological evaluation of different potencies of 6 Homoeopathic Drug Ricinus Communis E.N. Sundaram, P. Uma Maheswara Reddy, K.P. Singh, K.R. Janardanan Nair, Ch. Raveendar, C. Nayak

• Drug Proving

Pothos Foetidus – A multicentric double blind Homoeopathic Pathogenetic Trial 18 R. Shaw, Vikram Singh, V.A. Siddiqui, Rajpal, Vinay Kr. Singh, Hari Singh, P.C. Mal, A.K. Bhakat

• Clinical Verification

Fagopyrum esculentum – A multicentric clinical verification study conducted by CCRH 23 P.S. Chakraborty, J.P. Singh, M.K. Rai, Pramodji Singh, A.K. Vichitra, A.K.N. Singh, Deepa Chakraborty, D.K. Singh, Hari Singh, Mohan Singh, M.N. Sinha, Rajpal, R.K. Rai, S. Prakash, S.D. Pathak, S.R. Bhagat, Vikram Singh, Vijay K. Paul, V.K. Singh, Yogendar Rai & V.A. Siddiqui

• Clinical Research

An open clinical observational study on the usefulness of pre-defined 34 homoeopathic medicines in the management of chronic sinusitis Sunil S. Ramteke, C. Nayak, Vikram Singh, Praveen Oberai, Varanasi Roja

• Extra Mural Research

Double blind placebo controlled trial of homoeopathic medicines in the management 41 of withdrawal symptoms in Opium addicts and its alkaloid derivatives-dependents Ajay Grover, Bharat Bhushan, Rajesh Goel

• Case Record

Diabetic Distal Symmetric Polyneuropathy: A Case Study 45

Pratima Devi, Sabyasachi Biswas

• Instructions to Authors 54

INDIAN JOURNAL OF RESEARCH IN HOMOEOPATHY Volume 2, No. 4, 2008

noreply@blogger.com (devendra Kumar munta) — Mon, 25 Mar 2013 06:02:00 +0000

Title Page No.

• Editorial i

C. Nayak

• Fundamental Research

Modeling Physical-Chemical Properties of High Dilutions: an electrical conductivity study 1 Carla Holandino, Rafael Harduim, Venício Feo da Veiga, Sheila Garcia, Carlos Renato Zacharias.

• Drug Standardisation

Ultra Dynamised and Undynamised Dilutions of Alloxan at Micro-doses Influence 10 Selective Pancreatic Beta Cell and Hormonal Profile: An Experimental Approach Sunil Kumar, C. Nayak.

• Drug Proving

Paraffin: A Multicentric double blind Homoeopathic Pathogenetic Trial carried out by CCRH 20 Rajpal, V.A. Siddiqui, N.R. Dey, K.C. Das, Yogendra Rai, Vinay Kr Singh.

• Clinical Verification

Mentha piperita – A Multicentric Clinical Verification Study conducted by CCRH 26Chakraborty, J.P. Singh, M.K. Rai, Pramodji Singh, A.K. Vichitra, A.K.N. Singh, Deepa Chakraborty, D.K. Singh, Hari Singh, Mohan Singh, M.N. Sinha, Rajpal, R.K. Rai, Prakash, S.D. Pathak, S.R. Bhagat, Vikram Singh, Vijay K. Paul, V.K. Singh, Yogendar Rai & V.A. Siddiqui.

• Clinical Research

Clinical evaluation of homoeopathic therapy in the management of hyperlipoproteinemia 34 J.P. Govekar, V.K. Paul, K. Singh, Praveen Oberai, Varanasi Roja.

• Extra Mural Research

Immunological studies on Rheumatoid Arthritis treated with Homeopathic drugs: Results of the Pilot Study 42 Prakash Rao & Nagalakshmi Prasannam.

• Case Record

A big urinary calculus expelled with homoeopathic medicine 50A.K. Gupta, Jaya Gupta, V.A. Siddiqui & Alok Mishra.

• Instructions to Authors

Source: http://ccrhindia.org/IJRH.asp

INDIAN JOURNAL OF RESEARCH IN HOMOEOPATHY - Volume 2, No. 3, 2008

noreply@blogger.com (devendra Kumar munta) — Fri, 22 Mar 2013 12:41:00 +0000

Contents

Title Pages

• • Editorial i

C. Nayak

• Fundamental Research 1

Theory and Instrumentation related to potentised Homoeopathic Medicines

T Maity, D Ghosh & C R Mahata

• Drug Standardisation 6

Pharmacognosy of Prunus laurocerasus Linn-A Homoeopathic Drug

P. Padma Rao, K. Janardhan Reddy & H.C. Gupta

• Drug Proving 10

Ficus Religiosa: A multicentric double blind Homoeopathic Pathogenetic Trial (drug proving) carried out by CCRH

N.R. Dey, K.C. Das, Yogendra Rai, V. A. Siddiqui & Rajpal Singh

• Clinical Verification 15

Ferrum Picricum: A Multicentric Clinical Verification Study conducted by CCRH

P.S.Chakraborty, J.P.Singh, M.K.Rai, Pramodji Singh, A.K.Vichitra, A.K.N.Singh, Deepa Chakraborty, D.K.Singh, Hari Singh, Mohan Singh, M.N.Sinha, Rajpal Singh, R.K.Rai, S.Prakash, S.D.Pathak, S.R.Bhagat, Vijay K. Paul, V.K.Singh, Yogendar Rai & V.A. Siddiqui.

• Clinical Research 22

Role of Cephalandra indica Q in the management of Diabetes Mellitus as an add-on medicine along with conventional antidiabetics

Hafeezullah Baig, S. R. Sharma, Anita Sharma, Praveen Oberai, Debadatta Nayak & Alok Mishra

• Extra Mural Research 28

Diabetes mellitus – Defining scope and clinical approach for homoeopathic management

N. L. Tiwari & Prashant Tamboli

• Case Record 37

Menopausal Flushes: A bane for women

Bindu Sharma

• Instructions to Authors 45

INDIAN JOURNAL OF RESEARCH IN HOMOEOPATHY - Volume 2, No.1, 2008

noreply@blogger.com (devendra Kumar munta) — Wed, 20 Mar 2013 12:48:00 +0000

Contents

Page No.

• Editorial i

C. Nayak

• Fundamental Research

Application of HPTLC in the Standardization of a Homoeopathic 1 Mother Tincture of Nux Vomica

D.A. Shanbhag & Sunita Jayaraman

• Drug Standardisation

Standardisation of Homoeopathic Drugs – Castanea Sativa Mill. 8 Rao P.P., Subramanian P. , Reddy P.R., Reddy K.J.

• Drug Proving

Argemone mexicana - A multicentric double blind Homoeopathic 13 Pathogenetic Trial (Drug Proving) carried out by CCRH N.R. Dey, K.C. Das & Yogender Rai

• Clinical Verification

Amoora rohituka – A multicenteric clinical verification study 19 conducted by CCRH P.S. Chakraborty, J.P. Singh, M.K. Rai, Pramodji Singh, Hari Singh, S.R. Bhagat, V.A. Siddiqui, A.K.Vichitra, A.K.N. Singh, D.K. Singh, Mohan Singh, M.N.Sinha, Rajpal Singh, R.K. Rai, S. Prakash, S.D. Pathak, Vijay K. Paul, V.K.Singh, Yogendar Rai & Deepa Chakraborty

• Clinical Research

Clinical evaluation of homoeopathic medicines in Sinusitis 26 Sharma, K. Bhanu Murty, G.C. Sahagal, Bindu Sharma, K.S.V. Bharatalaxmi, Raju, & S. Ravi Kumar

• Extra Mural Research

Search for Potential Anticancer Agents - Evaluation of Anticancer 38 activity of Carcinosin, Apis and Thuja Soma Samanta, A.U. De, P.K. Tarafder and Tarun Jha

Study on effectiveness of homoeopathic bowel nosodes in the 42 treatment of cervical spondylosis on the basis of stool culture report Chaturbhuja Nayak

• Case Record

A Case of Vitiligo treated with Phosphorus 49 Ravi Kumar S.

• Instructions to Authors 58

INDIAN JOURNAL OF RESEARCH IN HOMOEOPATHY - Volume 1

noreply@blogger.com (devendra Kumar munta) — Tue, 19 Mar 2013 14:29:00 +0000

INDIAN JOURNAL OF RESEARCH IN HOMOEOPATHY

Volume 1, No. 1, 2007

Contents

Title

• Editorial

• Use of Homoeopathic Drugs as Antifungal Agent for the Protection of Books and Paper Materials

K.L. Garg

• A Study to clinically evaluate the Efficacy of Homoeopathic preparations of Cinnamonum Q, Erigeron Q, Ficus Religiosa Q, Geranium Maculatum Q, Thalapsi Bursa Pastoris Q, Ledum pal 30, 200, Trillium Pendulum Q in Menorrhagia

• Proving of Agave Americana

• Damiana – A Clinical Verification study

• Standardisation Of Homoeopathic Drug – Hypericum Perforatum L. P. Padma Rao, P. Subramanian and K. Janardhan Reddy

• A case of Hypothyroidism treated with Homoeopathic Medicine Dr.Reeta Bagai , Dr. B.S. Arya

• Benign Prostatic Hyperplasia (BPH) And Homoeopathy Search on InternetO.P.Verma

• Medi News

• Instructions To Authors

Source : http://ccrhindia.org/old_ijrh.asp

Indian Journal of Research in Homoeopathy

noreply@blogger.com (devendra Kumar munta) — Sun, 17 Mar 2013 12:55:00 +0000

IJRH

Indian Journal of Research in Homoeopathy (IJRH) is an internationally, research based peer reviewed, quarterly published Open Access online journal. This journal has been started with an aim to publish recent advances of research in the form of original research articles, short communications and review articles in Homoeopathy related to Drug Standardisation, Drug Proving, Clinical Verification, Fundamental Research, Clinical Research, and Case studies etc. The abstract of articles presented in this journal are also being published in Hindi to facilitate wider readership.

IJRH employs a highly rigorous peer-review and editing process to evaluate manuscripts for scientific accuracy, novelty, and importance.

IJRH is the most widely read, cited, and influential homoeopathic periodical in the world. As it evolves to meet the changing needs of its readers in the 21st century, it is committed to maintaining that reputation and integrity, while using innovative technologies for new features and faster delivery and access.

Our intention is to encourage eminent scientists to publish their research findings through our journal so that these findings pave a way for the budding scientists to enhance their knowledge.

ONLINE SUBMISSION OF MANUSCRIPTS

Subscription Form Guidelines to Authors

Source: http://ccrhindia.org/IJRH.asp

CCRH NewsLetter

noreply@blogger.com (devendra Kumar munta) — Sat, 16 Mar 2013 07:10:00 +0000

Newsletter

CCRH NEWS

Source: http://ccrhindia.org/Newsletter_Vol.asp

CCRH - International Collaborative Studies

noreply@blogger.com (devendra Kumar munta) — Fri, 15 Mar 2013 06:01:00 +0000

International Collaborative Studies

To widen its working horizon and for better research opportunities, CCRH collaborates with various organizations at the international level.

International Scientific Committee on Homoeopathy and Influenza

International Scientific Committee on Homoeopathy and Influenza (ISCHI) is one such international committee formed to combat Influenza pandemic in the world through homoeopathic medicines, with International Federation of Classical Homoeopathy (IFCH), European Committee of Homoeopathy (ECH), Royal London Homoeopathic Hospital (RLHH) and American Institute of Homoeopathy (AIH) as other members, besides CCRH. ISCHI had conducted a multi-nation survey on homoeopathic management of influenza like illness patients; India was one with other 6 countries (France, UK, USA, India, Brazil, Israel, Belanux).

University of California, Los Angeles, USA

Homoeopathy is second largest system of medicine among the Indian system of medicines. However, no studies have been conducted to assess the potential role of the homeopathic practitioner in providing HIV education and prevention. Moreover, no significant efforts have been made to utilize the services of homeopathic practitioners in the delivery of prevention messages to their patients, many of whom are at risk of acquiring HIV. To assess the potentials and utilize the homoeopathic physicians as the future disseminator of knowledge about HIV/AIDs prevention, the Council conducted collaborative studies with University of California with following objectives.

To build capacity and skills among homoeopathic practitioners and educators focusing HIV prevention.

Delivery of a model AIDS prevention and health promotion programs which can be replicated throughout India.

Study-I

A study was carried to assess the current level of HIV/AIDS cognitive and transmission related knowledge among homeopathic educators and practitioners; both of whom play critical roles in impacting HIV/AIDS in India. Thirty four (n=34) homoeopathic educators and 34 homoeopathic practitioners participated in the study. A 21 items AIDS knowledge and attitudes questionnaire was used for assessment. The results were found to be promising. The articles can be accessed at:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2396477/pdf/nem018.pdf and
http://www.psocommons.org/wmhp/vol2/iss1/art12/.

Study-II

Similarly another study was carried out in train the trainer concept about the delivery of model HIV prevention & health promotion programmes in India by homoeopathy and ayurvedic physicians & educators. The study was conducted in north India. Two hundred two (n=202) physicians of homoeopathy and ayurveda participated in the study. The results were encouraging. The detailed results of the study has been published, which can be accessed at: http://www.psocommons.org/wmhp/vol2/iss3/art4/.

PROTOCOL HOMOEOPATHIC PATHOGENETIC TRIAL (DRUG PROVING)

noreply@blogger.com (devendra Kumar munta) — Wed, 13 Mar 2013 12:35:00 +0000

1. Personnel:
(At CCRH/Headquarters)
Chief Coordinator : Director General, Central Council for Research In Homoeopathy, New Delhi
Co-Chief Coordinator : Deputy Director (H), Central Council for ResearchIn Homoeopathy, New Delhi
Coordinator : Assistant Director (H), Central Council for Research In Homoeopathy, New Delhi
(At Institute/ Unit level)
Programme Officer : Incharge of the Institute/Unit
Co-Chief Coordinator : Assistant Director (H)/ Research Officer (H) conducting theDrug Proving Programme at Institute/Unit.
(At Institute/ Unit of CCRH, functioning in Homoeopathic Medical College premises)
Drug Proving Committee*:

A Drug Proving Committee to be constituted by the Principal of Homoeopathic Medical College and duly approved by the Director General, Central Council for Research in Homoeopathy, New Delhi, will supervise the Drug Proving Programme. This Committee shall consist of the following members:

Chairman : Principal of the Homoeopathic Medical College.
Programme Officer : Incharge of Institute/Unit of the Council shall be the convener.
Members :
i, ˜Proving Master" who looking after the specific Drug Proving Programme at the Institute/Unit.

ii-iv, All Heads of the Departments of Organon, Materia Medica & Repertory of the respective Homoeopathic Medical College.

v, Convener may invite one teacher from the college or one specialist or one Officer of the Institute/Unit as Special Invitee in consultation with the Chairman.

vi, ˜Proving Associate" (One teacher from the Homoeopathic college) He / She will be closely associated with the Proving Master in day-to-day activities of the Drug Proving Programme.

Functions of the Drug Proving Committee

1. The committee will meet fortnightly during Drug proving to: -

i, scrutinize the data recorded by the Provers, Proving Master/Proving Associate.
ii, scrutinize the records of Pre-trial Medical Examinations (PME) carried out in the beginning of trial, Terminal Medical Examinations (TME) carried out at the conclusion of the trial and any other additional investigations or examinations carried out during the period of the trial.
iii, finalize/approve the proving data in respect of each coded drug.
2. The Proving Master will submit all relevant records to the Drug Proving Committee.
3. Incharge of the Institute/Unit will forward the Proving data, approved by the committee, to the Co-Chief Coordinator, the incharge of the Drug Proving Programme in the CCRH headquarters, New Delhi.
* If any member of the Committee retires or transferred or ceases to hold the post, he/she will be replaced by the successor with intimation to the Director General, CCRH
2. SITES WHERE STUDY WILL BE PERFORMED WITH THE NAME/DESIGNATION OF THE RESPECTIVE
PROGRAMME OFFICERS / PROVING MASTERS AT INSTITUTES/UNITS:*

S.No. Name of the Institute/Unit Programme Officer Proving Master
1. Central Research Institute (H), NOIDA Dr. J.P. Govekar, A.D. (H) Dr. A.K. Vichitra, A.D. (H)
2. Central Research Institute, Kottayam Dr. T. N. S. Kurup, D.D. (H) Dr. A.R. Sahoo, R.O. (H)
3. Homoeopathic Drug Research Institute, Lucknow Dr. A.N. Mishra, Project Officer Dr. S.D.Pathak, A.D. (H)
Dr. J.P.Singh, A.D. (H)
4. Regional Research Institute (H), Gudivada Dr. V.G. Prasad, A.D. (H) Dr. K. Banoth, R.O. (H)
5. Drug Proving Research Unit (H), Kolkata Dr. K.C. Das, A.D. (H) Dr. P.K. Chandra, A.D. (H)
6. Regional Research Institute (H), Puri (Extension Unit at Bhubaneswar) Dr. Goutam Rakshit, A.D. (H) Dr. Goutam Rakshit, A.D. (H)
Note: At the discretion of the Chief Coordinator, the Proving Master or any other staff connected with the Drug Proving Programme can be changed while conducting the programme.

3. INTRODUCTION
3.1- Background
Prior to Hahnemann, the systematic and extensive human experimentation of Drug had not been so meticulously done. In the history, about 2000 BC, there is the mention of Shen Nung, Emperor of China who tested herbs upon himself for eliciting therapeutical efficacy. Later, in the sixteenth century, Paracelsus, the veritable Luther of Medicine preferred medicines that he had tried on himself and the Zurich doctor, Conrad Gessner actually experimented drugs, usually derived from plants, on himself. Albrecht von Haller recommended this procedure but mostly for his work in physiology. Another person of note was the Viennese Anton Stoerck who tried the drugs first on animals, and then on him. It is surmised by some that Hahnemann, as a former Vienna student, may have got the idea from him. Hahnemann was the first person to provide a precise scientific basis for these desperate investigations, and bring them into a comprehensive therapeutic context. In his study of Cinchona Bark, which he carried out on himself in 1790 he observed that this drug produced the typical symptoms of Malaria. His experiments on Cinchona Bark led him to his formulate Law of Similars, and also marked the beginning of the systematic performance of homoeopathic drug provings.
˜Drug Proving is a method, unique to Homoeopathy where the pathogenesis of a drug is evolved through its trials on apparently Healthy Human Volunteers (Provers). Hahnemann, also well known as the Father of Experimental Pharmacology for developing a totally new principle for ascertaining the curative power of medicinal substances, tested 99 drugs in all, on himself, his family and his colleagues, in order to discover beyond doubt, the peculiar effects of drugs on human's health. In this context he stressed the need of proving drugs on healthy persons, which is the best way to obtain an unadulterated picture of the drug. In his ˜Organon of Medicine (?105 -145), Hahnemann gave detailed instructions regarding the method of homoeopathic drug proving in healthy subjects.
Keeping in view the importance of ˜Drug Proving" for the growth of Homoeopathy, the Council has undertaken the drug-proving programme on priority.

3.2- Rationale
The selection of Similimum is based on matching the symptom totality of the patient and drug and a correct symptom-totality of a drug can be obtained only by eliciting the effect of the drug on healthy human beings in various potencies. Therefore, Homoeopathic Pathogenetic Trial (Drug Proving) of a drug is essential to get this information.

3.3- Usefulness
Drug Proving is the building block of Homoeopathic Materia Medica. Primary action of a drug substance should be known before it can be taken as a ˜Homoeopathic Drug". A well-proved drug will help in the construction of an authentic Homoeopathic Materia Medica, which, in turn, will facilitate the selection of a Similimum, and in the annihilation of the disease.

3.4- Objective
To find out the pathogenetic effects of a drug on healthy human beings.

3.5- Hypothesis
The latent healing power of a drug is unfolded by the method of ˜Potentisation i.e. successive dilution followed by agitation and this is exhibited in the form of various signs and symptoms produced by the drug when it is given to healthy human beings.

3.6- Study design
3.6.1- The Central Council for Research in Homoeopathy is conducting systematic procedure of testing drugs on healthy human beings through Interventional, double blinded, randomized, placebo controlled, parallel study.

3.6.2- Locations of the study

1. Central Research Institute (H) NOIDA (Uttar Pradesh)
2. Central Research Institute, Kottayam, (Kerala)
3. Regional Research Institute (H) Gudivada (Andhra Pradesh)
4. Homoeopathic Drug Research Institute (H) Lucknow (Uttar Pradesh)
5. Drug Proving Research Unit (H) Kolkata (West Bengal),
6. Regional Research Institute (H), Ext. Unit of Puri Bhubaneswar (Orissa)

3.7- Approach
To prove or disprove the hypothesis as stated above.

3.8- Duration of study
Drug Proving is a continuous process and a complete proving trial of any drug takes time. A drug is believed proved well when any further trial of the drug on healthy persons does not give any additional or new symptom; therefore, no fixed duration of study can be prescribed. However, one Institute/Unit will be assigned three drugs to be proved in a year. One proving programme will consist of 3 quotas of the drug. Drug Proving will be on multi-centric basis. This will include selection of provers, Pre-trial medical examination (PME), completion of all quota(s) and post trial medical examination (TME). The same drug will be proved in different centers under the same protocol before releasing the data for professional use. Hence one drug may take 6 months to 1 year to be completed in all respects. This duration may however be extended in case the trial is not completed in the scheduled time at any Institute/Unit.
4 STUDY DESIGN IN DETAIL

4.1- Selection of provers
Applications (Form A) from 15-20 volunteers (out of which 6 including 3 males and 3 females should be from non- homoeopathic background) for each drug proving programme will be invited from apparently healthy, males & females above the age of 18 years through notices on notice boards of the Institutes/Units/College. The Incharge of the Institute/Unit, Proving Master/Proving Associate, teachers may motivate the students/staff of the Homoeopathic Medical College to participate in the Proving Programme.

4.2-Inclusion criteria

Age: Above 18 years of age.
Sex: Both male and female volunteers.
Health status: Experts acceptance for certifying that participant is healthy.
Participant must be two months clear of any homoeopathic remedy with no significant change in last 3 weeks.
Intelligent enough to record carefully the facts, subjective and objective symptoms generated by the drug during proving.

4.3-Exclusion criteria

Volunteers suffering from any acute or chronic disease.
Volunteers under any kind of medical treatment.
Hysterical or anxious persons (such individuals display a high incidence of ˜Placebo effects).
Persons having history of allergies, food hypersensitivity etc.
Women during pregnancy, puerperium and while breast-feeding.
Persons with colour blindness.
Persons having addictions- brandy, wine, alcohol, narcotics, tobacco
Persons who has undergone surgery in last two months.
Hysterical, prone to hypersensitivity reactions (Like asthma, allergies), Anxiety prone, emotionally disturbed, colour-blind, suffering from any chronic disease, pregnant, puerperal, lactating females.
Previous homoeopathic treatment in last two months
Participation in another clinical or proving trial during the last 6 months

4.4- Written Informed Consent
A ˜Written Informed Consent (Form B) must be obtained from each selected volunteers before starting the drug proving. All volunteers will be informed about the objectives, benefits of the trial through Provers Information Sheet (Form C). Proving will be conducted in potencies only, which ensures non-toxic state of the trial drug and thereby considered safe for the provers.
All the volunteers will undergo:

i) General Examination (Form D, Part-I), to be done by the Proving Master/Proving Associate,

ii) Pre-trial Medical Examinations (Form D, Part-II), to be done by the Honorary Consultants,

iii) Pathological report (Form D, Part-III) to be prepared by a pathologist.

4.5- Photograph
Each selected prover will have to provide his/her two photographs, to Proving Master in full pose, facing camera for record.
Note- Complete PMEs (Form D, Part I, II, III) of volunteers declared fit by the Honorary Consultants for Drug Proving will be sent to Co-Chief Coordinator (Drug Proving) at CCRH/Hqrs., New Delhi alongwith copy of application & Written Informed Consent for allotting code numbers and supply of drug quota to start Drug proving programme.)

5- DRUG TRIAL
After the final approval of the Chief Coordinator, Director General, CCRH/Hqs., New Delhi, the provers will be awarded code numbers and the coded drug of different quotas will be supplied by CCRH/Hqrs., New Delhi in separate phials bearing code number pertaining to respective provers. The drug will be taken as per instructions (Methodology) given below.
6. Methodology for Drug Proving

Study Design

Design recommended
Study Type: Interventional Study Design: Allocation Randomized
Control: Placebo Control
Intervention Model: Parallel Assignment
Masking: Double Blind

Source and Nature of testing substance
One source can be Pharmacopeias where the details are explained
For new substances:
Medicinal plant grown in the research garden and standardized subsequently, as per requirement of pharmacopeia
Complete identification of the substance- Plant, animal, mineral, etc.
Part to be taken up and its justification
Justification of the new substance being proved including the background literature, pharmacological, toxicological literature available about the substance
Medicine should be procured from a pharmacy having GMP certification
Pre-trial Medical Examination (PME): It is conducted to confirm health status of the volunteers. The volunteers declared healthy, are enrolled as ˜Provers" in the study.

Coding
Each prover is allotted a code number which bears drug code, proving center code and his/her serial number. The same code number is also labeled on the glass phials of the drug to be proved (Verum or placebo, as the case may be) by him/her. The coding of the drug/placebo is done at the CCRH headquarters.

Potencies to be proved

POTENCIES
PROPOSED 6C, 30C, 200C
LM (for pilot proving)
Order In ascending order
Placebo/td> Placebo consists of pure sucrose globules that are not potentiated but impregnated with dispensing alcohol. The administration scheme is identical in the placebo control group to that of the intervention group

Dose
The study consists of different quotas (as per different potencies). Each quota of the drug is given in 12 doses. Each dose consists of 4 pills (Size 20) to be taken dry on tongue. The provers are asked to take 4 doses in a day (4 hourly) for 3 days of a particular quota of the coded drug.
Duration of each quota may vary in accordance with development of symptoms while the prover is taking regular doses as mentioned above.

Process of Proving

Dietary guidelines for Provers- Prover to follow the normal daily routine and dietary habits. Prover should avoid as far as possible all potential antidoting factors such as tea, coffee, recreational drugs, camphor, eucalyptus, menthol, mint and any substance they are sensitive to during proving.
Before commencing the study, all the volunteers are screened as per the Protocol. Each prover notes down daily, the details of his/her feelings/changes in mind and body, after taking the drug, in the ˜Proverâ Day Book Proforma.

A. If no sign(s)/symptoms(s) appear:

Prover may not develop any sign/symptom till the completion of 12 doses; even if no sign&/symptom is observed, the prover notes down as ˜No Symptom with date and time of intake of the respective dose of the drug.

B. If sign(s)/symptoms(s) appear:

The prover is asked to stop taking the drug as soon as he/she feels any change or any sign(s) &/or symptoms(s) develop during the trial. The prover notes down the sequence of the appearance of new sign(s) &/or symptoms(s), their progress and the number of doses after which each sign &/or symptom appears with date, time of onset and duration for which it persists. The intake of drug remains suspended till the sign(s) &/or symptoms(s) totally disappear.

Each prover is interrogated by the Proving Master/Proving Associate to verify the sign(s) &/or symptom(s) recorded by him/her in ˜Prover's Day Book Proforma everyday. The verified symptoms are recorded in 'Symptoms Elaboration Proforma' with complete details in respect of their location, sensation, modalities and concomitants by the Proving Master.

During the course of proving, the prover is referred for specific laboratory investigation(s) to rule out any pathological cause for appearance of new symptom(s)/sign(s). Laboratory tests are performed to facilitate observation of any correlation between the subjective and objective changes during the course of proving. The opinion of the experts is also taken, on the appearance of new sign(s)/symptom(s), wherever needed.

C. Resume intake of Drug

After disappearance of sign(s) &/or symptom(s) developed by the drug, the prover has to wait for a further period of thirty days (washout period). If the washout period is symptom free, the prover may start intake of doses from the next quota (potency) of the drug again in the same dose schedule i.e. 4 doses/day and follow the process A and B.

Terminal Medical Examination (TME)

After completion of proving of all potencies (quotas), the provers are examined by the specialists again, and the process is called 'Terminal Medical Examination' (TME).

Decoding

The proved drug is decoded after receiving ˜Prover's Day Book Proformae, ˜Symptoms Elaboration Proformae, ˜Pathological Report Sheets and ˜Terminal Medical Examination sheets' from all the proving centers at CCRH headquarters before compilation.

Compilation

The sign(s) &/or symptom(s) generated by verum (drug) or placebo (control) on each prover are noted down with prover code, name of the proving center, stage, number of doses after which each of the signs or symptoms appeared and the duration for which they persisted. The sign(s) &/or symptom(s) generated by verum group, are separated from those generated by provers of control group. The sign(s) &/or symptom(s) which were produced by the placebo as well as the drug in provers, are not taken into consideration. The sign(s) &/or symptom(s) generated by the provers kept on drug are compiled as per the schema of the Kents Repertory i.e. Mind, Vertigo, Head, Eye, Ear,Generalities.

Criteria for selection of symptoms
As per the appearance of Symptoms;
Selection on the basis of comparison (both intra prover and inter prover) with controls (Exactly same symptoms to be discarded keeping in view appearance in number of controls vis-Ã -vis verum group)
Classification of symptoms as stated below
(RS)- Recent symptoms i.e. a symptom that you are suffering from now, or have been suffering from in the last year.
(NS)- New symptom.
(OS)- Old symptom. State when the symptom occurred previously.
(AS)- Alteration in present or old symptom. (e.g. used to be left side, now on the right side)
(US)- An unusual symptom for you.

7-SAMPLE SIZE

At least 15 provers from one centre, out of which 6 (3 males and 3 females) should be from non- homoeopathic background.
Screening procedures
Social desirability scale

8-ETHICAL CONSIDERATION
Council's Drug Proving Programme has been duly approved and cleared by the Ethical Committee of the Council with the following observations/guidelines:

Safety for the volunteers is an important prerequisite in Drug Proving

The drug substance will be administered in potency only, which is known to provoke transient ˜proving" symptoms, but does not cause toxicological effects.

The prover should be in such a mental, physical state as to be able to exercise fully his/her power of choice.

The nature and purpose of the drug proving must be explained to the provers.

The investigator or the investigating team should discontinue the proving if in his/her or their judgement, the proving, if continued, may be harmful to the prover.

9-REPORTING PROFORMAE
Since a large amount of information is obtained from a prover, the following formats for data recording will be adopted while conducting Drug Proving:
PRE-TRIAL/ POST-TRIAL MEDICAL EXAMINATION (PME/TME) REPORTS PROFORMA (Form-D)“is for recording the state of the health of the subjects both before and after the Drug Proving trial. These proformae are to be filled in by the Honorary Consultants/incharge of the Laboratories attached to the Drug Proving Research Institute/Unit on the basis of the findings on examination of the subjects, as follows:

Parts of Form-D Examiner System(s) to be examined
Part â€“I Proving Master/
Proving Associate ˜Health status of the volunteer
Part-II Psychiatrist ˜Psychological Examination
General Physician Examination of ˜Respiratory system,
General Examination of ˜Gastro-Intestinal System,
General Examination of ˜Cardiac system"
Examination of ˜Nervous System,
Examination of ˜Genitalia (Male) and
Examination of ˜Urinary system
Gynaecologist Examination of ˜Genitalia (Female) and ˜Menstruation"
Ophthalmologist Examination of ˜Eye"
E.N.T. specialist Examination of ˜Ear and
Examination of ˜Nose & Throat"
Dermatologist Examination of ˜Skin"
Pathologist ˜Pathological Examination"
Part-III X-Ray
(Out sourcing) Chest X-Ray

Proformae used in Drug Proving

Provers Day Book Proforma (P.D.B.P.) - For the prover, to record the subjective symptoms or deviations, if any, from his/her normal condition(s) of life during TRIAL PERIOD, observed after the intake of the trial drug.

Symptoms Elaboration Proforma - To be filled in by the Proving Master/Proving Associate the details of each symptom recorded by the prover in the P.D.B.P. i.e. location, sensation, modality, concomitant & extension, etc.

Pathological Report Sheet - To be filled in by the Pathologist at the time of PME/TME and during the proving.

10. PERIODICAL REPORTS (Form-I & J)
Monthly (Form I) & Quarterly/Annual reports (Form J) will be submitted to CCRH/New Delhi through the Incharge the Institute/Unit in the first week of the month/reporting period.

11- PARTICIPATION CERTIFICATE
A participation certificate will be awarded by the Central Council for Research in Homoeopathy, New Delhi only to the students from Homoeopathic Medical Colleges, who participate in Council's proving programme fully till the conclusion of relevant drug proving programme.

12-ACKNOWLEDGEMENT
Involvement of authorities of the Homoeopathic Medical College, Head of the Departments/teachers and students will be duly acknowledged for associating in the proving programme.

13-DATA SHARING
Final compiled proved data (Drug Pathogenesis) of the drug would also be made available to college authorities for academic interest.

Collaborative Research - CCRH

noreply@blogger.com (devendra Kumar munta) — Tue, 12 Mar 2013 18:07:00 +0000

The Council collaborates with various institutes of excellence to utilise the potential of the best of the brains, in order to yield the maximum results. The main objective of the collaborative studies is to conduct evidence-based, inter-disciplinary research studies and to validate the efficacy of Homoeopathy on scientific parameters. Collaborative research programmes with reputed institutes like School of Tropical Medicine (Kolkata), Central Institute of Psychiatry (Ranchi), Indian Institute of Technology & Defence Institute of Physiology & Allied Sciences (Delhi), Bose Institute (Kolkata), University of Madras (Chennai), Bhabha Atomic Research Centre (Trombay) etc. are in progress.

CONCLUDED STUDIES:-

Collaborative study with Nav Chetna Drug-de-addiction Centre, Varanasi.
Title of the study: Evaluation of efficacy of Homoeopathic Treatment of Drug dependants (September 1988 - March 1994)
Collaborative study with Homoeopathic Pharmacopoeia Laboratory, Ghaziabad.
Title of the study: A chemo-pharmacological study of Hypericum perforatum anti-inflammatory action on Albino rats - (1988)
Collaborative study with Department of Gastroenterology, AIIMS, New Delhi.
Title of the study: In-vitro effects of Homoeopathic drugs on HBV associated DNA Polymerase activity - (1988)
Collaborative study with Regional Medical Research Centre (ICMR), Orissa.
Title of the study: A single blind study on effect of Homoeopathic treatment on Filariasis - (1991-92)
Collaborative study with Banaras Hindu University.
Title of the study: Morpho-Histological and Pychological analysis of the Anti-fertility Effects of Pulsatilla
Collaborative study with Banaras Hindu University, Varanasi.
Title of the study: Effect of 1000 & 10000 potencies of Pulsatilla on Ovaries, Uteril and Arcuate Neurons in Albino Rats.
Amla Cancer Research Centre and Hospital, Trichur, Kerala.
Title of the study: Homoeopathic medicines useful in Tumor reduction
International Collaborative study with University of California Los Angeles (UCLA).
Title of the study: Collaborative study on AIDS prevention with Traditional Medicine - (2003-04)
Jawahar Lal Institute of Post-Graduate Medical Education & Research (JIPMER), Puducherry.
Title of the study: Effect of Homoeopathy drugs used on Serum Melatonin and Cortisol levels in healthy volunteers- (2008-09)
Osmania University, Hyderabad.
Title of the study: Effect of Homoeopathic drugs on Central nervous System and their safety evaluation- (2009-10)
Osmania University, Hyderabad.
Title of the study: Efficacy and Safety evaluation of Homoeopathic Drugs in Experimental Animals- Endocrinological Studies- (2007-08)
Homoeopathic Research Foundation (HRF), Lucknow.
Title of the study: To evolve a group of most efficacious Homoeopathic Medicines in Bengin Prostatic Hyperplasia with regard to improvement in the symptom complex- (2009-10)
Bhabha Atomic Research Center, Trombay.
Title of the study: A Multicenter Study on Action of Homoeopathic Medicines and Potencies on HRV and BFV with Medical Analyzer System - (2009-10)
Jamia Hamdard, New Delhi.
Title of the study: Studies on Homoeopathic medicines for the treatment of Cerebral ischemia - (2008-09)
Regional Medical Research Center (ICMR), Port Blair.
Title of the study: Anti-leprosprial activities of Homoeopathic medicines - (2010-11)

ONGOING STUDIES:-

Indian Institute of Technology, New Delhi.
Title of the study: A structural study of homoeopathic medicine; A pilot study.
Defense Institute of Physiology and Allied Sciences (DIPAS), Delhi.
Title of the study: Exploration of the Utility of GDV Camera as a Diagnostic Instrument in the Areas of Homoeopathic Fundamental Research - A pilot study
Society for Promotion of Youth & Masses, New Delhi and Darjeeling.
Title of the study: A multicentric open clinical study to evaluate the efficacy of indicated Homoeopathic medicines. I) in the management of lapse of alcohol and opioid drug addictions II) In the management symptoms of withdrawal symptoms of alcohol and opioid drug addiction and III) in the prevention of relapse of alcohol and Opioid drug abuse, New Delhi and Darjeeling.
School of Tropical Medicine, Kolkata.
Title of the study: Effect of Homoeopathic Medicines on Japanese Encephalitis Virus infection on choriioallantoic membrane & suckling Mice
High Security Animal Diseases Laboratory, Bhopal.
Title of the study: To study the in-vivo efficacy of a panel of homoeopathic drugs, against H5N1 Virus in chicken
Central Institute of Medicinal and Aromatic Plants, Lucknow.
Title of the study: To evaluate the biological activity of five coded Homoeopathic drugs on plants using Bacopa Test as model system
Central Institute of Psychiatry, Ranchi.
Title of the study: An open clinical trail to ascertain role of Add on Homoeopathic therapy in the management of Schizophrenia
Central Institute of Psychiatry, Ranchi.
Title of the study: An open clinical trial to ascertain role of Add on Homoeopathic therapy in the management of Depression
Bose Institute, Kolkata.
Title of the study: Role of homoeopathic medicines in cancer regression and rejuvenation of depressed immune system
Indian Veterinary Research Institute, Izatnagar.
Title of the study: To evaluate certain homoeopathic medicines for their immuno- modulatory and antioxidant potential
Defence Institute of Physiology and Allied Sciences(DRDO), New Delhi.
Title of the study: The day after effect of Arnica 30 on delayed onset muscle soreness(DOMS)
Dr A.C, Homeopathic Medical College, Bhubaneswar, Regional Research Institute(H), Mumbai.
(Bhabha Atomic Research Center)
Title of the study: A multicenter study on action of homoeopathic medicines and potencies on heart rate variability (HRV) and blood flow variability (BFV) with medical Analyzer System
Dr. ALM Post Graduate Institute of Basic Medical Sciences, University of Madras.
Title of the study: Anti-diabetic properties of Homoeopathic preparation of Syzigium jambolanum and Cephalandra-indica
Dr. ALM Post Graduate Institute of Basic Medical Sciences, University of Madras.
Title of the study: Protective role of Homoeopathic preparation of Berberis vulgaris to alleviate Kidney stone disease and its influence on molecular events leading to Calcium oxalate crystal deposition

Source: http://ccrhindia.org/Information_ccrh.asp

Request to CCRH

noreply@blogger.com (devendra Kumar munta) — Mon, 11 Mar 2013 18:06:00 +0000

Reishmi Devan

Thanks.

Do CCRH have any professional videos in English on Introduction to Homeopathy for public viewing.

Regards,
Dr.Reishmi
Malaysia

.................................................................

12:44am

Amita Arora

kindly accept my FR at DrAmita Arora.

..................................................................

Jaishree Reddy

! i want to register myself from central council,please giv information

.................................................

8:49am

Mamta Solanki

good morning
can you suggest me some topic of research related to homeopathy and management because i m going to do my project dissertation work so your suggestion may be helpful to me
thank you

....................................................

11:53am

Swapan Chandra

good morning dr. how r u ? I want discuss on hypothyroidism & it's management through homeopathy.....whats in your mind

..........................................

Indu Saraswat's Request to CCRH

noreply@blogger.com (devendra Kumar munta) — Mon, 11 Mar 2013 17:57:00 +0000

Indu Saraswat

sir , i ihv a nice request to u......... i wnt to know sm information regarding... dr. shree radhakrishnan university jodhpur, the name of rajasthan ayurved university is nw changed b4 1 year.............. ayush sent u sm day b4 gajett notifaication . i wnt to know this notification cch sent or not to the lucknow. bcs we r feeling lot of difficulty without notification, dt is possible only after gajett notification receiving in lucknow. please sir reply me dis is my humble request to cch or u... thnk u

Source: Facebook.com